Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Plos One|October 22, 2016
MUC1-ARF-A Novel MUC1 Protein That Resides in the Nucleus and Is Expressed by Alternate Reading Frame Translation of MUC1 mRNAMichael Chalick, Oded Jacobi, Edward Pichinuk, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2011
BRAF activation induces transformation and then senescence in human neural stem cells: a pilocytic astrocytoma modelEric H Raabe, Kah Suan Lim, Julia M Kim, et al.
Human Pathology|November 4, 2015
PD-L1 (B7-H1) expression and the immune tumor microenvironment in primary and metastatic breast carcinomasAshley Cimino-Mathews, Elizabeth Thompson, Janis M Taube, et al.
Cancer Immunology, Immunotherapy : CII|March 29, 2020
In vivo anti-MUC1+ tumor activity and sequences of high-affinity anti-MUC1-SEA antibodiesEdward Pichinuk, Michael Chalik, Itai Benhar, et al.
Oncoimmunology|July 29, 2016
The ratio of CD8 to Treg tumor-infiltrating lymphocytes is associated with response to cisplatin-based neoadjuvant chemotherapy in patients with muscle invasive urothelial carcinoma of the bladderAlexander S Baras, Charles Drake, Jen-Jane Liu, et al.
Cell Reports|April 14, 2024
Context-dependent roles for ubiquitous mitochondrial creatine kinase CKMT1 in breast cancer progressionVinay Ayyappan, Nicole M Jenkinson, Caitlin M Tressler, et al.
Scientific Reports|September 24, 2021
Proteomic characterization of primary and metastatic prostate cancer reveals reduced proteinase activity in aggressive tumorsQing Kay Li, Jing Chen, Yingwei Hu, et al.
Breast Cancer Research and Treatment|September 19, 2019
High mobility group A1 (HMGA1) protein and gene expression correlate with ER-negativity and poor outcomes in breast cancerMikhail Gorbounov, Neil M Carleton, Rebecca J Asch-Kendrick, et al.
Human Pathology|September 25, 2016
Immune-checkpoint status in penile squamous cell carcinoma: a North American cohortMargaret Cocks, Diana Taheri, Mark W Ball, et al.
Brain Pathology (Zurich, Switzerland)|July 24, 2026
ALT phenotype assessment in IDH-mutant astrocytoma supports biologic consequence of ATRX missense mutationsOguzhan O Kizilkaya, Kevin Y Zhang, Mohamed Sherief, et al.
Pageof 4